Bisphenol A and risk of metabolic disorders

JAMA

Volumn 300, Issue 11, 2008, Pages 1353-1355

  Vom Saal, Frederick S ^a   Myers, John Peterson ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Environmental Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PLASTIC;

DISEASE PREDISPOSITION; EDITORIAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; FOOD AND DRUG ADMINISTRATION; HEALTH HAZARD; HIGH RISK POPULATION; METABOLIC DISORDER; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR;

EID: 51949113574     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.11.1353     Document Type: Editorial

References (23)

1. Lang IA, Galloway TS, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008;300(11):1303-1310.
2. Richter CA, Birnbaum LS, Farabollini F, et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol. 2007;24(2):199-224.
3. Wetherill YB, Akingbemi BT, Kanno J, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol. 2007;24(2):178-198.
4. Environment Canada. Draft Screening Assessment for The Challenge: Phenol, 4,4′-(1-methylethylidene)bis-(Bisphenol A). Chemical Abstracts Service Registry No. 80-05-7. Environment Canada Web site. http://www.ec.gc.ca/ substances/ese/eng/challenge/batch2/batch2_80-05-7.cfm. 2008. Accessibility verified August 20, 2008.
5. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24(2):139-177.
6. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115(6):876-882.
7. Bindhumol V, Chitra KC, Mathur PP. Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology. 2003;188(2-3):117-124.
8. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE. 2008;3(4):e2069.
9. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes [published online August 14, 2008]. Environ Health Perspect. doi:10.1289/ehp.11537.
10. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures, III: endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006;147(6)(suppl):S56-S69.
11. Trautmann N. The dose makes the poison - or does it? ActionBioscience.org Web site. http://www.actionbioscience.org/environment/trautmann.html. 2005. Accessed August 7, 2008.
12. vom Saal FS, Akingbemi BT, Belcher SM, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24(2):131-138.
13. National Toxicology Program (NTP). Draft NTP brief on bisphenol A. NTP Web site. http://cerhr.niehs.nih.gov/chemicals/bisphenol/ BPADraftBriefVF_04_14_08.pdf. April 14, 2008. Accessed July 5, 2008.
14. European Food Safety Authority. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to 2,2-BIS(4-HYDROXYPHENYL)PROPANE (Bisphenol A). EFSA J. 2006;428:1-76.
15. Statement of Norris Alderson. PhD, Associate Commissioner for Science, Food and Drug Administration, Department of Health and Human Services, before the Subcommittee on Commerce, Trade and Consumer Protection, Committee on Energy and Commerce, US House of Representatives. US Food and Drug Administration Web site. http://www.fda.gov/ola/2008/BPA061008.html. June 10, 2008. Accessed August 12, 2008.
16. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27(1):127-133.
17. vom Saal FS, Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect. 2005;113(8):926-933.
18. Michaels D. Doubt Is Their Product: How Industry's Assault on Science Threatens Your Health. New York, NY: Oxford University Press; 2008.
19. Taylor JA, Welshons WV, vom Saal FS. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24 hr after administration in neonatal female mice. Reprod Toxicol. 2008;25(2):169-176.
20. De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res. 2007;4(4):285-296.
21. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int J Androl. 2008;31(2):201-208.
22. Prins GS, Birch L, Tang WY, Ho SM. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol. 2007;23(3):374-382.
23. Anastas PT, Beach ES. Green chemistry: the emergence of a transformative framework. Green Chem Let Rev. 2007;1(1):9-24.